Studies in advance have shown that microglia-mediated deleterious effects in ALS could be prevented by genetic ablation of P2X7 receptor or by using specific antagonists to the receptor (58, 59, 62). The gene discussed is P2RX7; the disease is amyotrophic lateral sclerosis.